|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 December 2017 |
|
Main ID: |
NCT03367650 |
|
Date of registration:
|
28/11/2017 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Epidemiology and Genetics of the Amyotrophic Lateral Sclerosis in the French West Indies
SLA-DOM |
|
Scientific title:
|
Epidemiology and Genetics of the Amyotrophic Lateral Sclerosis in the French West Indies |
|
Date of first enrolment:
|
May 13, 2014 |
|
Target sample size:
|
70 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT03367650 |
|
Study type:
|
Interventional |
|
Study design:
|
Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Guadeloupe
|
Martinique
| | | | | | |
|
Contacts
|
|
Name:
|
Annie LANNUZEL, Professor, Neurological |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Hospital University Center of Pointe-à-Pitre |
|
|
Name:
|
Chantal LERUS, Director of Clinical Research |
|
Address:
|
|
|
Telephone:
|
0590 93 46 86 |
|
Email:
|
chantal.lerus@chu-guadeloupe.fr |
|
Affiliation:
|
|
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patient or third-party responsible for receiving information on the study and who
signed informed consent ;
- Patient age over 18 years;
- Patient living in the Antilles;
- Patient with ALS or SLP (primary lateral sclerosis, pure central form of ALS).
Exclusion Criteria:
- Patient non-affiliated to the social security scheme ;
- in case of difficulty of monitoring patient, exclusion of the longitudinal study.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Amyotrophic Lateral Sclerosis
|
|
Intervention(s)
|
|
Dietary Supplement: Blood sample and environmental survey
|
|
Primary Outcome(s)
|
|
the impact of amyotrophic lateral sclerosis in Guadeloupe and Martinique
[Time Frame: Through study completion, an average of 6 years]
|
|
Secondary Outcome(s)
|
|
Study the genetic factors of the ALS
[Time Frame: Through study completion, an average of 9 years]
|
|
Clinical criteria of SLA
[Time Frame: Through study completion, an average of 9 years]
|
|
Estimate prevalence of the ALS
[Time Frame: Through study completion, an average of 6 years]
|
|
Secondary ID(s)
|
|
RBM-PAP-2013/55
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|